Synthesis and antitumor activity of conjugates of muramyldipeptide, normuramyldipeptide, and desmuramylpeptides with acridine/acridone derivatives

Journal of Medicinal Chemistry

Volumn 44, Issue 22, 2001, Pages 3606-3615

  Dzierzbicka, K ^a   Kolodziejczyk, A M ^a   Wysocka Skrzela, B ^a   Mysliwski A ^b   Sosnowska, D ^b  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ACRIDONE DERIVATIVE; AMIDE; CARBOXYLIC ACID; DESMURAMYLPEPTIDE; GLUTAMINE; HYDROXYL GROUP; MURAMYL DIPEPTIDE; NORMURAMYLDIPEPTIDE; SUGAR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONJUGATE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HAMSTER; HUMAN; HUMAN CELL; MALE; NONHUMAN;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ACRIDINES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; CRICETINAE; CYTOTOXICITY, IMMUNOLOGIC; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KILLER CELLS, NATURAL; MALE; MESOCRICETUS; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0035950163     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm001115g     Document Type: Article

References (45)

1. Muramylpeptides: Immunomodulators, sleep factors and vitamins
2. Muramylpeptides and lipopeptides: Studies towards immunostimulants
3. Muramylpeptides as immunomodulators
4. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal ptoperties in rat alveolar macrophages
5. Potentiation of antitumor cytotoxicity and production of timor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivative
6. Potentiation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state
7. Natural killer sensitivity of tumor cells isolated from primary and metastatic lesions of four Bomirski melanoma variants
8. The in vitro effect of new muramyl peptide derivatives on cytotoxic activity of NK (Natural Killer) cells from hamsters bearing Ab Bomirski melanoma
9. Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis
10. Synergistic effect of immuno-modulators of muramyl peptides type with other medicines
11. Synthesis of 6-O-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with antitumor activity
12. Synthesis of long chain fatty acid esters of N-acetyl-muramylL-alanyl-D-isoglutamine in relation to anti-tumour activity
13. Synthesis, and the adjuvant and tumorsuppressive activities of quinonyl muramyl dipeptides
14. 9-derivatives of 1-, 2-, 3-, and 4-nitro9-aminoacridine
15. In vitro studies on the cytotoxic properties of 9-aminoacridine derivatives
16. The mode of action of cytotoxic and antitumor 1-nitroacridines III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridines
17. 14C-(3′-dimethylamino-Npropylamino)acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells
18. Research on tumour inhibiting compounds. Part LXVI. Synthesis of some amino acid derivatives of 1-nitroacridine
19. Potential antitumour agents. 12. 9-Anilinoacridines
20. Inhibitory effect of FK-565 alone and in combination with zidovudine on retroviral infection by Friend Leukemia Virus in mice
21. Synthesis of N-acetylmuramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response and some N-acetylmuramyl peptide analogs
22. Synthesis of lipophilic muramyl dipeptide derivatives via O-aminoacyl intermediates
23. Synthesis of muramyl dipeptide conjugated with acridine derivatives, showing anti-HIV-1 and anticancer activity
24. Synthesis and in vitro anticancer activity of conjugates of MDP with amino-acridine/acridone derivatives
25. Synthesis and anticancer activites of new MDP conjugates with amino-acridine/acridone derivatives
26. New improved synthesis of protected meso-diaminopimelyl-(S)-R-alanine
27. New convenient synthesis ofimmunostimulating peptides containing meso-diaminopimelic acid
28. Preliminary observation of the ledakrin effect in treatment of patients with lung carcinoma
29. Ledakrin in treatment of colon carcinoma
30. Antitumor activity of 1-nitro-9-aminoacridine derivatives
31. The mode of action of cytotoxic and antitumour 1-nitroacridines. II. In vitro enzyme mediated covalent binding of 1-nitroacridine derivative Ledakrin or Nitracrine with DNA and other macromolecules of mammalian or bacterial cells
32. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking
33. Products of metabolic activation of the antitumor drug Ledakrin (Nitracrine) in vitro
34. Selective toxicity of nitracrine to hypoxic mammalian cells
35. Reductive metabolism and hypoxia-selective metabolism of nitracrine
36. Development of Mean Graph and COMPARE Algorithm
37. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
38. The in vivo influence of new MDP derivative: MDP(Ala)C921 on the spleen NK (Natural Killer) activity and the serum level of IL-2 in hamsters bearing Ab Bomirski melanoma
39. A new class of antitumor agents: Conjugates of MDP and acridine/acridone derivatives
40. NMR studies of the MDP conjugates with amino- acridine/acridone derivatives
41. The natural history of a family of transplantable melanomas on hamsters